24) Reactivators of AChE as Therapeutics (ReACT)
Abstract
Focuses on therapeutic strategies to effectively minimize injuries resulting from exposure to CWAs. This effort involves the development of improved therapies for enzyme reactivation. Efforts in this area are designed to develop potential candidates that will ultimately be submitted for Food and Drug Administration (FDA) licensure or to identify previously licensed products for new uses in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- 5f0dcd6451c36bfaffa94f99698f8621